Skip to content

Hemab Therapeutics Holdings

US · COAG #3007 by market cap Listed 2026
28.70 +0.33 +1.16%
Live - 5344 symbols - heartbeat 246s ago · 2026-10-08 02:52
After-hours 28.70 0.00%
Overnight 28.37 -1.15%
Market cap
1.34B
P/B
2.95
EPS
-1.45
Reader sentiment Are you bullish or bearish on COAG?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 4 analysts

Buy
Avg price target 54.25 +89.0%
Price target rangecurrent 28.70
Low46.00
Avg54.25
High64.00
Buy 100% Hold 0% Sell 0%
Recent ratings (14)
DateFirmAnalystRatingTarget
2026-08-12 Wedbush -- BUY 64.00
2026-08-11 H.C. Wainwright -- BUY 60.00
2026-07-13 Wedbush -- BUY 55.00
2026-07-13 Jefferies -- BUY 47.00
2026-07-13 Goldman Sachs -- BUY 46.00
2026-07-13 H.C. Wainwright -- BUY 52.00
2026-06-29 Wedbush -- BUY 42.00
2026-06-26 H.C. Wainwright -- BUY 40.00
2026-06-17 H.C. Wainwright -- BUY 40.00
2026-06-08 Jefferies -- BUY 39.00
2026-05-26 Wedbush -- BUY 42.00
2026-05-26 Jefferies -- BUY 39.00
2026-05-26 Evercore -- BUY 50.00
2026-05-26 Goldman Sachs -- BUY 36.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Quote time 2026-10-08 02:52:22 · For reference only, not investment advice and not tailored to your situation.